Research News

Drug eluting stents match bypass surgery for mortality in registry study, but trial shows higher event rate

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1489 (Published 17 March 2015) Cite this as: BMJ 2015;350:h1489
  1. Susan Mayor
  1. 1London

Percutaneous coronary intervention (PCI) with second generation drug eluting stents is associated with similar mortality as coronary artery bypass grafting (CABG) in patients with multi-vessel coronary artery disease, the results of a real world registry study have shown,1 but a randomised trial found a higher event risk.2

The observational registry study,1 reported in the New England Journal of Medicine, compared 9223 patients who underwent PCI using everolimus eluting stents with 9223 patients who underwent CABG. The two groups were selected from a New York registry of 34 819 …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe